Australia markets closed

Thiogenesis Therapeutics, Corp. (TTI.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.68000.0000 (0.00%)
At close: 01:08PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
28/02/2022
28/02/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-4,707
-5,063
-3,924
-224.457
-92.678
-
-
Stock-based compensation
386.927
480.914
524.366
-
-
27.949
0
Change in working capital
-49.409
1,334
-568.807
157.381
56.8
-
-
Accounts receivable
-76.661
-64.07
-7.991
-
-
0.8862
-2.286
Accounts payable
-
1,406
-642.663
-
-
27.064
-17.2584
Other working capital
-4,369
-3,248
-2,090
-67.076
-35.878
-
-
Other non-cash items
-
-
1,935
-
-
3.5054
-
Net cash provided by operating activities
-4,369
-3,248
-2,090
-67.076
-35.878
-
-
Cash flows from investing activities
Net cash used for investing activities
-
0
107.457
-
-
-
-
Cash flows from financing activities
Debt repayment
-
0
-175.172
-
-
-
-
Common stock issued
-
4,121
4,880
-
-
0
352.6929
Other financing activities
-
-
-
-194.542
-
-
-
Net cash used provided by (used for) financing activities
4,584
4,121
8,127
3,327
0.11
-
-
Net change in cash
205.227
880.347
6,133
3,260
-35.768
-
-
Cash at beginning of period
5,319
6,196
62.549
146.431
182.199
-
-
Cash at end of period
5,533
7,076
6,196
3,406
146.431
-
-
Free cash flow
Operating cash flow
-4,369
-3,248
-2,090
-67.076
-35.878
-
-
Free cash flow
-4,369
-3,248
-2,090
-67.076
-35.878
-
-